Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
about
Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Impairment of Serotonergic Tra ...... isms and Clinical Implications
@en
type
label
Impairment of Serotonergic Tra ...... isms and Clinical Implications
@en
prefLabel
Impairment of Serotonergic Tra ...... isms and Clinical Implications
@en
P2860
P356
P1476
Impairment of Serotonergic Tra ...... isms and Clinical Implications
@en
P2093
Abdelhamid Benazzouz
Philippe De Deurwaerdère
P2860
P356
10.3389/FNCEL.2017.00274
P577
2017-09-12T00:00:00Z